COMBIHALE FB 400 INHALER

Description

COMBIHALE FB 400 Inhaler combines Formoterol Fumarate (a long-acting beta-2 agonist) and Budesonide (an inhaled corticosteroid) in a metered-dose inhaler to provide effective dual therapy for patients with asthma and chronic obstructive pulmonary disease (COPD).

Formoterol works by relaxing the airway muscles, leading to bronchodilation and easier breathing, while budesonide reduces airway inflammation to prevent exacerbations and improve lung function. This inhaler is designed for regular maintenance use to control symptoms and reduce flare-ups.

Key Benefits:

• Provides sustained bronchodilation and anti-inflammatory effects

• Helps prevent asthma attacks and COPD exacerbations

• Easy-to-use metered-dose inhaler for precise drug delivery

• Improves overall lung function and quality of life

Indications:

• Maintenance treatment of asthma

• Management of chronic obstructive pulmonary disease (COPD)

Dosage:
Use as prescribed by the healthcare provider, usually 1-2 puffs twice daily.

Precautions:
Not intended for acute bronchospasm relief. Use under medical supervision. Possible side effects include oral thrush and tremors; rinse mouth after use.